Analytical Data
-
基因名
TPD52
- Application
-
别名
Protein N8
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P55327
-
表达区间
1-184aa
-
分子量
35.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TPD52 (Tumor Protein D52) is a member of the TPD protein family that has garnered significant interest in cancer research due to its upregulation in various malignancies. Initially identified as a protein associated with tumor formation, TPD52 has been implicated in critical cellular processes such as cell proliferation, apoptosis, and migration. Studies have shown that TPD52 is overexpressed in several cancer types, including breast, prostate, and lung cancers, suggesting a potential role as a biomarker for tumor progression. The mechanism of action of TPD52 appears to involve the modulation of signaling pathways related to growth factors and oncogenes, possibly influencing the transcriptional regulation of genes involved in cancer development. Researchers have been particularly focused on understanding the structural and functional properties of TPD52 to explore its potential as a therapeutic target. By investigating the underlying molecular interactions and pathways that TPD52 participates in, scientists aim to develop innovative strategies for cancer treatment and early detection. Furthermore, the study of TPD52 has implications beyond oncology, as it may also contribute to our understanding of cellular differentiation and neurobiology. Overall, the research surrounding TPD52 is crucial for elucidating its role in tumorigenesis and developing targeted therapies that could improve clinical outcomes for cancer patients.
